» Articles » PMID: 20005451

Lin28-let7 Modulates Radiosensitivity of Human Cancer Cells with Activation of K-Ras

Overview
Specialties Oncology
Radiology
Date 2009 Dec 17
PMID 20005451
Citations 104
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: To evaluate the potential of targeting Lin28-let7 microRNA regulatory network for overcoming the radioresistance of cancer cells having activated K-Ras signaling.

Methods And Materials: A549 lung carcinoma cells and ASPC1 pancreatic cancer cells possessing K-RAS mutation were transfected with pre-let7a microRNA or Lin28 siRNA, respectively. Clonogenic assay, quantitative reverse transcription polymerase chain reaction, and Western analysis were performed. The effects of Lin28 on SQ20B cells having wild-type K-RAS, and a normal fibroblast were also assessed.

Results: The overexpression of let-7a decreased expression of K-Ras and radiosensitized A549 cells. Inhibition of Lin28, a repressor of let-7, attenuated K-Ras expression and radiosensitized A549 and ASPC1 cells. Neither SQ20B cells expressing wild-type K-RAS nor HDF, the normal human fibroblasts, were radiosensitized by this approach.

Conclusions: The Lin28-let7 regulatory network may be a potentially useful therapeutic target for overcoming the radioresistance of human cancers having activated K-Ras signaling.

Citing Articles

Development of miRNA-based PROTACs targeting Lin28 for breast cancer therapy.

Xu J, Zhao X, Liang X, Guo D, Wang J, Wang Q Sci Adv. 2024; 10(38):eadp0334.

PMID: 39292784 PMC: 11409961. DOI: 10.1126/sciadv.adp0334.


RNA-binding proteins and exoribonucleases modulating miRNA in cancer: the enemy within.

Seo Y, Rhim J, Kim J Exp Mol Med. 2024; 56(5):1080-1106.

PMID: 38689093 PMC: 11148060. DOI: 10.1038/s12276-024-01224-z.


Regulating Protein-RNA Interactions: Advances in Targeting the LIN28/Let-7 Pathway.

Oyejobi G, Yan X, Sliz P, Wang L Int J Mol Sci. 2024; 25(7).

PMID: 38612395 PMC: 11011352. DOI: 10.3390/ijms25073585.


Basic and translational research on carbon-ion radiobiology.

Sai S, Koto M, Yamada S Am J Cancer Res. 2023; 13(1):1-24.

PMID: 36777517 PMC: 9906076.


Expression patterns of platinum resistance-related genes in lung adenocarcinoma and related clinical value models.

Wang Z, Mu L, Feng H, Yao J, Wang Q, Yang W Front Genet. 2022; 13:993322.

PMID: 36506331 PMC: 9730711. DOI: 10.3389/fgene.2022.993322.